High HbA1c levels after the percutaneous cardiovascular intervention may help identify patients at long-term risk for adverse CV events.
Veronica Hackethal, MD
The new term is not meant merely to “re-brand” obesity, but to frame it as a chronic disease with distinct complications.
This screening model may improve retinopathy detection in patients with T1DM and decrease costs.
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
Do low-risk CVD patients with T2DM experience the same significantly lower all-cause and CV mortality seen in high-risk patients?
A small pilot study is the first to report on bone health in people with an at least 50-year history of type 1 diabetes.
How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?
Eight top apps for endocrinologists include decision support tools, printable patient handouts, calculators, and treatment guidelines.
The study also compared psychosocial variables, including treatment satisfaction, well-being, and fear of hypoglycemia, during CGM vs self-monitoring.
The American Heart Association released a statement about the impact meal timing and frequency has on cardiometabolic health and obesity.